SWTX
Closed
Springworks Therapeutics Inc
46.99
+0.01 (+0.02%)
Last Update: 30 Jun 2025 23:25:00
Yesterday: 46.98
Day's Range: 46.98 - 47.01
Send
sign up or login to leave a comment!
When Written:
24.64
SpringWorks Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with rare diseases and cancer. The company was founded in 2017 and is headquartered in Stamford, Connecticut.
SpringWorks is developing a pipeline of potential therapies that target specific genetic mutations and disease pathways. Their lead product candidate, nirogacestat, is being developed for the treatment of desmoid tumors, a rare and often debilitating type of tumor that can occur anywhere in the body.
In addition to nirogacestat, SpringWorks has several other product candidates in various stages of development, including therapies for neurofibromatosis type 1, multiple myeloma, and other rare diseases.
SpringWorks has partnerships with several leading academic institutions, including Memorial Sloan Kettering Cancer Center and Fred Hutchinson Cancer Research Center, as well as collaborations with other biopharmaceutical companies.
As of 2021, SpringWorks Therapeutics Inc. is a publicly traded company listed on the Nasdaq stock exchange under the ticker symbol SWTX.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
SpringWorks is developing a pipeline of potential therapies that target specific genetic mutations and disease pathways. Their lead product candidate, nirogacestat, is being developed for the treatment of desmoid tumors, a rare and often debilitating type of tumor that can occur anywhere in the body.
In addition to nirogacestat, SpringWorks has several other product candidates in various stages of development, including therapies for neurofibromatosis type 1, multiple myeloma, and other rare diseases.
SpringWorks has partnerships with several leading academic institutions, including Memorial Sloan Kettering Cancer Center and Fred Hutchinson Cancer Research Center, as well as collaborations with other biopharmaceutical companies.
As of 2021, SpringWorks Therapeutics Inc. is a publicly traded company listed on the Nasdaq stock exchange under the ticker symbol SWTX.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!